Market Tracker

12/08 4:59pm ET

OPKO Health Inc (NASDAQ:OPK)

10.81
Delayed Data
As of 4:00pm ET
 -0.12 / -1.10%
Today’s Change
7.12
Today|||52-Week Range
11.85
+7.56%
Year-to-Date
Why Opko Health Shares Climbed 9% in November
3:49pm / MotleyFool.com - Paid Partner Content
Opko Health: Rayaldee Makes This Stock Worth Watching
Dec 01 / MotleyFool.com - Paid Partner Content
Weekly CEO Buys Highlights
Dec 05 / GuruFocus News - Paid Partner Content
OPKO Health (OPK) Launches Kidney Drug Rayaldee in U.S.
Nov 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close10.93
Today’s open10.88
Day’s range10.61 - 10.91
Volume3,301,556
Average volume (3 months)3,382,730
Market cap$6.1B
Dividend yield--
Data as of 4:00pm ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-40.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratioNM
Price/Sales9.97
Price/Book3.01

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...+1.20+1.19%
UTHRUnited Therapeutics ...+0.36+0.27%
IONSIonis Pharmaceutical...+0.56+1.22%
MNKMallinckrodt Plc+0.99+1.93%
Data as of 4:02pm ET, 12/08/2016

Financials

Next reporting dateMarch 6, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts